Medistim ASA (OL:MEDI) — Stock Price
Medistim ASA (OL:MEDI) is currently trading at Nkr226.00 NOK, down 0.88% today. Over the past 52 weeks, shares have ranged between Nkr188.00 and Nkr284.00. This page tracks Medistim ASA's live share price on the OL exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see MEDI market cap overview.
Medistim ASA (MEDI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Medistim ASA's daily closing share price and trading volume on the OL exchange over the past year, giving a clear view of recent price momentum and liquidity.
Medistim ASA Income Statement — Revenue, Profit & Earnings by Year
Medistim ASA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Nkr562.60 Million | Nkr526.36 Million | Nkr491.94 Million | Nkr417.82 Million | Nkr356.21 Million |
| Cost of Revenue | Nkr113.68 Million | Nkr112.28 Million | Nkr106.48 Million | Nkr97.11 Million | Nkr76.58 Million |
| Gross Profit | Nkr448.92 Million | Nkr414.08 Million | Nkr385.45 Million | Nkr320.70 Million | Nkr279.63 Million |
| Research & Development | — | — | — | — | — |
| SG&A | Nkr197.17 Million | Nkr170.37 Million | Nkr154.01 Million | Nkr28.46 Million | Nkr23.92 Million |
| Total Operating Expenses | Nkr425.09 Million | Nkr389.68 Million | Nkr345.01 Million | Nkr204.43 Million | Nkr184.15 Million |
| Operating Income | Nkr131.08 Million | Nkr131.44 Million | Nkr141.25 Million | Nkr116.28 Million | Nkr95.48 Million |
| EBITDA | — | — | Nkr169.46 Million | Nkr137.68 Million | Nkr114.89 Million |
| EBIT | Nkr131.08 Million | Nkr131.44 Million | Nkr141.25 Million | Nkr114.25 Million | Nkr91.75 Million |
| Interest Expense | Nkr490.00K | Nkr151.00K | Nkr123.00K | Nkr178.00K | Nkr146.00K |
| Income Before Tax | Nkr134.25 Million | Nkr135.21 Million | Nkr146.05 Million | Nkr114.07 Million | Nkr91.61 Million |
| Income Tax Expense | — | — | Nkr32.08 Million | Nkr23.17 Million | Nkr22.22 Million |
| Net Income | Nkr103.83 Million | Nkr103.82 Million | Nkr113.97 Million | Nkr90.90 Million | Nkr69.39 Million |
Medistim ASA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Medistim ASA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Nkr574.97 Million | Nkr505.72 Million | Nkr482.66 Million | Nkr403.24 Million | Nkr345.82 Million |
| Total Current Assets | Nkr429.13 Million | Nkr391.57 Million | Nkr385.89 Million | Nkr306.50 Million | Nkr245.79 Million |
| Cash & Equivalents | — | — | — | Nkr129.49 Million | Nkr71.89 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Nkr68.98 Million | Nkr74.30 Million | Nkr101.66 Million | Nkr73.52 Million | Nkr60.47 Million |
| Inventory | Nkr160.52 Million | Nkr145.39 Million | Nkr114.33 Million | Nkr97.41 Million | Nkr112.67 Million |
| Property, Plant & Equipment | Nkr73.16 Million | Nkr57.30 Million | Nkr57.10 Million | Nkr58.86 Million | Nkr64.68 Million |
| Goodwill | Nkr14.13 Million | Nkr14.13 Million | Nkr14.13 Million | Nkr14.13 Million | Nkr14.13 Million |
| Total Liabilities | Nkr138.36 Million | Nkr107.78 Million | Nkr114.97 Million | Nkr97.19 Million | Nkr88.97 Million |
| Total Current Liabilities | Nkr107.37 Million | Nkr94.28 Million | Nkr99.82 Million | Nkr77.60 Million | Nkr59.48 Million |
| Long-term Debt | — | — | — | Nkr0.00 | Nkr7.58 Million |
| Net Debt | — | — | — | Nkr-100.67 Million | Nkr-26.65 Million |
| Total Stockholder Equity | Nkr436.61 Million | Nkr397.94 Million | Nkr367.69 Million | Nkr306.05 Million | Nkr256.85 Million |
| Retained Earnings | Nkr328.80 Million | Nkr307.38 Million | Nkr302.53 Million | Nkr240.16 Million | Nkr203.90 Million |
Medistim ASA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Medistim ASA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Nkr143.10 Million | Nkr113.19 Million | Nkr114.56 Million | Nkr128.14 Million | Nkr74.13 Million |
| Capital Expenditures | Nkr24.69 Million | Nkr29.73 Million | Nkr9.25 Million | Nkr11.49 Million | Nkr10.64 Million |
| Free Cash Flow | Nkr118.41 Million | Nkr89.47 Million | Nkr92.39 Million | Nkr116.65 Million | Nkr63.49 Million |
| Investing Cash Flow | Nkr-24.69 Million | Nkr-29.73 Million | Nkr-21.10 Million | Nkr-11.49 Million | Nkr-10.64 Million |
| Financing Cash Flow | Nkr-91.53 Million | Nkr-84.88 Million | Nkr-70.30 Million | Nkr-59.05 Million | Nkr-58.35 Million |
| Dividends Paid | Nkr82.41 Million | Nkr82.18 Million | Nkr68.40 Million | Nkr54.64 Million | Nkr50.05 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Nkr24.51 Million | Nkr23.66 Million | Nkr23.29 Million | Nkr23.43 Million | Nkr23.14 Million |
| Change in Cash | Nkr25.34 Million | Nkr1.23 Million | Nkr23.15 Million | Nkr57.60 Million | Nkr5.15 Million |
Medistim ASA Earnings History — EPS Actual vs. Analyst Estimates
Track Medistim ASA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 07, 2026 | — | — | — |
| Feb 27, 2026 | — | 1.45 | — |
| Oct 24, 2025 | 1.90 | 1.41 | +34.72% |
| Aug 20, 2025 | 2.35 | 1.44 | +63.53% |
| May 09, 2025 | 2.37 | 1.43 | +65.73% |
| Feb 28, 2025 | 1.16 | 1.44 | -19.44% |
| Oct 24, 2024 | 1.28 | 1.54 | -16.88% |
| Aug 16, 2024 | 1.90 | 1.47 | +28.97% |